Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Matei

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
Frontiers in Oncology|February 12, 2024
E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cellsAndres Valdivia, Matthew Cowan, Horacio Cardenas, et al.
Cancer Research|September 18, 2002
Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motilityLindsay Gillan, Daniela Matei, David A Fishman, et al.
Plos One|March 4, 2014
Small molecule inhibitors target the tissue transglutaminase and fibronectin interactionBakhtiyor Yakubov, Lan Chen, Alexey M Belkin, et al.
Oncogene|September 6, 2002
Gene expression in epithelial ovarian carcinomaDaniela Matei, Thomas G Graeber, Rae Lynn Baldwin, et al.
Cancers|April 11, 2019
A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian CancerNkechiyere G Nwani, Salvatore Condello, Yinu Wang, et al.
Cancer Research|December 3, 2009
Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminaseMinghai Shao, Liyun Cao, Changyu Shen, et al.
Scientific Reports|October 16, 2020
Intracellular optical doppler phenotypes of chemosensitivity in human epithelial ovarian cancerZhe Li, Ran An, Wendy M Swetzig, et al.
Nature Communications|May 13, 2022
Skilful decadal-scale prediction of fish habitat and distribution shiftsMark R Payne, Gokhan Danabasoglu, Noel Keenlyside, et al.
Nucleic Acids Research|January 27, 2011
PDGF induced microRNA alterations in cancer cellsMinghai Shao, Simona Rossi, Bhadrani Chelladurai, et al.
Gynecologic Oncology|July 5, 2016
Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancerMaria de Leon, Horacio Cardenas, Edyta Vieth, et al.
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
Frontiers in Oncology|February 12, 2024
E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cellsAndres Valdivia, Matthew Cowan, Horacio Cardenas, et al.
Cancer Research|September 18, 2002
Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motilityLindsay Gillan, Daniela Matei, David A Fishman, et al.
Plos One|March 4, 2014
Small molecule inhibitors target the tissue transglutaminase and fibronectin interactionBakhtiyor Yakubov, Lan Chen, Alexey M Belkin, et al.
Oncogene|September 6, 2002
Gene expression in epithelial ovarian carcinomaDaniela Matei, Thomas G Graeber, Rae Lynn Baldwin, et al.
Cancers|April 11, 2019
A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian CancerNkechiyere G Nwani, Salvatore Condello, Yinu Wang, et al.
Cancer Research|December 3, 2009
Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminaseMinghai Shao, Liyun Cao, Changyu Shen, et al.
Scientific Reports|October 16, 2020
Intracellular optical doppler phenotypes of chemosensitivity in human epithelial ovarian cancerZhe Li, Ran An, Wendy M Swetzig, et al.
Nature Communications|May 13, 2022
Skilful decadal-scale prediction of fish habitat and distribution shiftsMark R Payne, Gokhan Danabasoglu, Noel Keenlyside, et al.
Nucleic Acids Research|January 27, 2011
PDGF induced microRNA alterations in cancer cellsMinghai Shao, Simona Rossi, Bhadrani Chelladurai, et al.
Gynecologic Oncology|July 5, 2016
Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancerMaria de Leon, Horacio Cardenas, Edyta Vieth, et al.
Pageof 19